Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Angiotech begins phase II trial with micellar paclitaxel for psoriasis

Nov. 27, 2000

Licensing opportunity from NIH: smad3 protein inhibition to enhance wound healing

Nov. 20, 2000

Steroid-free eczema treatment recommended for FDA approval

Nov. 17, 2000

Cellegy seeks approval of Rectogesic in New Zealand

Nov. 15, 2000

MBI-594AN advances to phase II for treatment of acne

Nov. 10, 2000

Connetics' foam formulation for scalp dermatoses launched in U.S.

Nov. 9, 2000

SmithKline Beecham reveals new chemokine receptor antagonists and their potential use

Nov. 7, 2000

News from ICACI 2000: IL-4/IL-5 inhibitor exerts beneficial effects in models of atopic dermatitis

Oct. 31, 2000

Microsponge formulation of 5-FU approved by FDA for actinic keratoses

Oct. 31, 2000

RXR-selective retinoids synthesized at Allergan for use in skin and other disorders

Oct. 27, 2000

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...